DIEBLER v. SANMEDICA INTERNATIONAL, LLC

District Court, D. New Jersey·Decided December 29, 2021·No. 1:19-cv-20155·Unknown

Opinion

[Doc. No. 85]

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY CAMDEN VICINAGE

HOLLY DEIBLER, et al.,

Plaintiff,

v. Civil No. 19-20155(NLH/MJS)

SANMEDICA INTERNATIONAL, LLC, at al.,

Defendant.

O P I N I O N & O R D ER This matter is before the Court on the “Motion to Compel compliance with Rule 45 Subpoenas” [Doc. No. 85] (the “Motion”) filed by defendant SanMedica International, LLC (“Defendant”). The Court is in receipt of the opposition filed by non-party attorneys for Plaintiff, Clarkson Law Firm, P.C. (“CLF”), Tycko & Zavareei, LLP (“TZ”), and Miller Shah LLP (“MS”) (collectively “Plaintiff’s Counsel”) [Doc. No. 94] as well as Defendant’s reply [Doc. No. 98]. The Court exercises its discretion to decide the Motion without oral argument. See FED. R. CIV. P. 78; L. CIV. R. 78.1. For the following reasons, Defendant’s Motion to compel as to CLF and TZ will be DENIED without prejudice to refile and the Motion to compel as to MS will be DENIED. I. Background Plaintiff Holly Deibler (“Plaintiff”) filed this putative class action on November 13, 2019 challenging the efficacy, advertisement, and sale of SeroVital-Hgh (“Serovital”), a

purported Human Growth Hormone supplement produced by Defendant. See Doc. No. 1. Plaintiff and the putative class are represented by MS, CLF, and TZ.1 In connection with this action, Defendant issued subpoenas to Plaintiff’s Counsel on November 30, 2020, to which Plaintiff’s Counsel objected.2 See Br. in Supp. at *2. Following a conference call with the Court on April 12, 2021, Defendant emailed revised, narrowed subpoenas to Plaintiff on April 15, 2021 and again on April 29, 2021.3 Id. at *4. These

1 Mr. Shah and Mr. Zipperian, of Miller Shah LLP, are counsel of record for Plaintiff in this matter. Counsel from CLF and TZ have been admitted pro hac vice in this matter. See Doc. Nos. 12, 28, and 44.

2 The Court notes that Mr. Shah was formerly a member of the firm Shepherd, Finkelman, Miller & Shah, LLP (“SFMS”). On March 15, 2021, Mr. Shah filed a Notice of Change of Firm Affiliation, Address and Email Address [Doc. No. 69] from SFMS to MS. The Court will treat the subpoena to SFMS as to MS, noting that Plaintiff has raised no objection.

3 On April 15, 2021, Defendant served notices of subpoenas and subpoenas duces tecum to CLF, TZ, and MS with the narrowed requests, which required production in the District of New Jersey, specifically at Mr. Cohen’s law office in Hackensack, New Jersey. See Declaration of Ronald F. Price ¶ 9, Exhibit E [Doc. No. 85- 2]. Thereafter, Plaintiff’s counsel served objections to the April 15, 2021 subpoenas. One of the objections – that the subpoenas required production more than 100 miles from the offices of the Plaintiff’s counsel - was not addressed during the call, although it had been previously raised in letter exchanges between the parties. In response, defendant served new, updated subpoenas. See Price Decl. ¶ 11, Exhibit F. These subpoenas indicated that the iterations of the subpoenas requested Plaintiff’s Counsel to provide the following: All Court Orders that either (1) approve or appoint as class counsel in any class action case any of the attorneys who are currently counsel of record for plaintiff in the matter captioned Holly Deibler v. SanMedica International, LLC, Civil Action No. 1:19- cv-20155, United Sates District Court, District of New Jersey (the “Deibler Matter”), or (2) refuse to approve, or otherwise deny motions to approve, as class counsel any of the attorneys who are currently counsel of record for plaintiff in the Deibler Matter.

Id. On May 13, 2021, Plaintiff’s Counsel again served objections, stating they would not comply with the subpoenas. Id. at *5. Specifically, Plaintiff’s Counsel objected to the subpoenas as (1) overly broad and seeking materials not relevant to any party’s claims or defenses and having no bearing upon Plaintiff’s Counsel’s adequacy to serve as class counsel, (2) not limited in temporal scope, (3) unduly burdensome, and (4) requesting information available to the public and defendant. See Declaration of Ronald F. Price ¶ 12, Exhibit G [Doc. No. 85-1, 85-2]. II. Legal Standards Pursuant to Federal Rule of Civil Procedure 45, a party may compel production of documents within the “possession, custody, or

requested records were to be produced and picked up by courier at the respective law firm offices in Los Angeles (CLF), Oakland (TZ), and Collingswood, New Jersey (MS). Defendant’s Motion seeks compliance with the most recent April 29, 2021 version of the subpoenas. See Br. in Supp. at *2. control” of non-parties. Specifically, “. . . the serving party may move the court for the district where compliance is required for an order compelling production . . . ” FED. R. CIV. P.

45(d)(2)(B). The permissible scope of discovery sought under Rule 45 is the same as Rule 26(b). In re Novo Nordisk Sec. Litig., 530 F. Supp. 3d 495, 501 (D.N.J. 2021). Under Rule 26(b)(1), [p]arties may obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit. Information within this scope of discovery need not be admissible in evidence to be discoverable.

FED. R. CIV. P. 26(b)(1). Under Rule 26(b)(2)(C), [o]n motion or on its own, the court must limit the frequency or extent of discovery otherwise allowed by these rules or by local rule if it determines that: (i) the discovery sought is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive; (ii) the party seeking discovery has had ample opportunity to obtain the information by discovery in the action; or (iii) the proposed discovery is outside the scope permitted by Rule 26(b)(1).

FED. R. CIV. P. 26(b)(2)(C); see also New Jersey Physicians United Reciprocal Exch. v. Boynton & Boynton, Inc., No. CIV.A. 12-5610, 2014 WL 4352327, at *4 (D.N.J. Sept. 2, 2014) (“[a]ll discovery is subject to the limitations imposed by Rule 26(b)(2)(C).”). Rule 26 is to be construed liberally in favor of disclosure, as relevance is a broader inquiry at the discovery stage than at the trial stage. Tele–Radio Sys. Ltd. v. De Forest Elecs., Inc.,

92 F.R.D. 371, 375 (D.N.J. 1981). “Although the scope of discovery under the Federal Rules is unquestionably broad, this right is not unlimited and may be circumscribed.” Bayer AG v. Betachem, Inc., 173 F.3d 188, 191 (3d Cir. 1999). A party seeking discovery bears the initial burden of demonstrating the requested discovery is relevant to its claim or defense. Morrison v. Phila. Housing Auth., 203 F.R.D. 195, 196 (E.D.Pa. 2001). Once that initial burden is met, “the objecting party must demonstrate ‘that the requested documents either do not come within the broad scope of relevance defined pursuant to Federal Rule of Civil Procedure 26(b)(1) or else are of such marginal relevance that the potential harm occasioned by discovery would outweigh the ordinary presumption in

favor of broad disclosure.’” Baier v. Princeton Off. Park, L.P., No. 3:08-CV-5296, 2018 WL 5253288, at *4 (D.N.J. Oct. 22, 2018) (quoting Barnes Found. v. Twp. of Lower Merion, No. CIV. A. 96- 372, 1996 WL 653114, at *1 (E.D. Pa. Nov.

Free access — add to your briefcase to read the full text and ask questions with AI

DIEBLER v. SANMEDICA INTERNATIONAL, LLC, (D.N.J. 2021).

DIEBLER v. SANMEDICA INTERNATIONAL, LLC (DIEBLER v. SANMEDICA INTERNATIONAL, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bayer AG v. Betachem, Inc.
173 F.3d 188 (First Circuit, 1999)
Reid v. Cumberland County
34 F. Supp. 3d 396 (D. New Jersey, 2013)
United States ex rel. Ortiz v. Mount Sinai Hospital
169 F. Supp. 3d 538 (S.D. New York, 2016)
Morrison v. Philadelphia Housing Authority
203 F.R.D. 195 (E.D. Pennsylvania, 2001)
Sanyo Laser Products, Inc. v. Arista Records, Inc.
214 F.R.D. 496 (S.D. Indiana, 2003)
Travelers Indemnity Co. v. Metropolitan Life Insurance
228 F.R.D. 111 (D. Connecticut, 2005)